By comprehensively understanding these transcriptional, post‐transcriptional, and post‐translational regulatory mechanisms, we can gain a better insight into the role of ARD1 in various types of cancers and provide theoretical support for the development of future ARD1‐based therapies (Figure 4). The gene discussed is NAA10; the disease is cancer.